Parameter
| Biomarker | IL-6 | Full name | Interleukin 6 | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnosis, Prognosis, Pharmacodynamics/Response |
| Disease | Schizophrenia | Disease Subtypes | / | ||
| Organ | Brain | Test Sample / Technology Platform | Plasma/Cerebrospinal Fluid (ELISA, Electrochemiluminescence Immunoassay) | ||
| Pathobiological Mechanisms | Pro-inflammatory factor activates microglia, inhibits neurogenesis, disrupts the blood-brain barrier, and synergizes with HPA axis dysfunction. | ||||
| Clinical Availability Status | Under clinical validation | ||||
| Notes and Dynamics | Levels are significantly elevated in treatment-resistant patients; anti-inflammatory therapy can improve symptoms. | ||||